Oct 22, 2026 08:53AM

Oct 6, 2026 08:58AM

Oct 6, 2026 08:55AM

Oct 1, 2026 09:20AM

Oct 1, 2026 09:20AM

Sep 30, 2026 08:33AM

Sep 30, 2026 08:32AM Ernexa Therapeutics Reports Compelling ERNA-101 Safety Results Across Three Critical IND-Enabling Studies, Advancing Toward Planned Q4 2026 IND

Sep 17, 2026 08:42AM

Sep 17, 2026 08:42AM

Sep 15, 2026 08:42AM

Sep 15, 2026 08:42AM

Jul 15, 2026 10:42AM

Jun 17, 2026 08:48AM

Jun 17, 2026 08:47AM Ernexa Therapeutics Positioned to Become a Clinical-Stage Biotechnology Company as ERNA-101 On Track for Planned Q3 2026 IND Submission and First-in-Human Study

Mar 31, 2026 08:55AM

Mar 31, 2026 08:55AM

Feb 3, 2026 08:45AM

Jan 6, 2026 08:15AM

Jan 6, 2026 08:15AM

335,194 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All